VAERS Explorer
Back to explore

Report #2897860

Received May 26, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
May 13, 2026
Onset
May 16, 2026
Days to onset
3
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (1)

Rash pruritic

Symptom narrative

dermatomal rash/ The rash itches; This non-serious case was reported by a consumer and described the occurrence of itchy rash in a 44-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included atazanavir sulfate;cobicistat (Evotaz). On 13-MAY-2026, the patient received Shingrix .5 ml. On 16-MAY-2026, 3 days after receiving Shingrix, the patient experienced itchy rash (Verbatim: dermatomal rash/ The rash itches). The outcome of the itchy rash was not resolved. It was unknown if the reporter considered the itchy rash to be related to Shingrix. It was unknown if the company considered the itchy rash to be related to Shingrix. Additional Information: GSK Receipt Date:19-MAY-2026 The batch number was not provided upon follow up with the reporter.

Other medications

EVOTAZ